Vijaya Diagnostic Centre Limited — Others, 12-05-2025: Appointment

Vijaya Diagnostic Centre has announced a board meeting on which it approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2025, with auditors issuing an unmodified opinion. A final dividend of ₹2 per share (200% on ₹1 face value) has been proposed, pending shareholder approval. Mr. S. Ramachandra Reddy has been appointed Interim CFO, and Mr. Lanka Sai Srinivas has joined as Chief Technology Officer. The firm re-appointed M/s. Santhosh & Associates as Cost Auditors for FY 2025-26. Additionally, 1,91,150 employee stock options were granted at ₹815 each, vesting over 1–4 years with a 10-year exercise period.